These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 23953622)

  • 21. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs.
    Mitchell JA; Warner TD
    Nat Rev Drug Discov; 2006 Jan; 5(1):75-86. PubMed ID: 16485347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology of selective COX-2 inhibitors.
    Capone ML; Tacconelli S; Sciulli MG; Patrignani P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M; Ruschitzka F
    Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
    Vuolteenaho K; Moilanen T; Moilanen E
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
    Laine L
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R; Rubin G; Berenbaum F; Scheiman J
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2 inhibitors: pharmacological data and adverse effects.
    Mattia C; Coluzzi F
    Minerva Anestesiol; 2005; 71(7-8):461-70. PubMed ID: 16012420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of Adverse Effects Associated with Nonsteroidal Anti-inflammatory Drugs and COX-2 Inhibitor].
    Masuda R
    Masui; 2016 Aug; 65(7):709-717. PubMed ID: 30358302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.
    Moore RA; Derry S; McQuay HJ
    BMC Musculoskelet Disord; 2007 Aug; 8():73. PubMed ID: 17683540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is there a future for COX-2 inhibitors?].
    Yodfat Y
    Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of correlation between the central anti-nociceptive and peripheral anti-inflammatory effects of selective COX-2 inhibitor parecoxib.
    Urdaneta A; Siso A; Urdaneta B; Cardenas R; Quintero L; Avila R; Suarez-Roca H
    Brain Res Bull; 2009 Aug; 80(1-2):56-61. PubMed ID: 19463915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.
    Borer JS; Simon LS
    Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S14-22. PubMed ID: 16168077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
    Coruzzi G; Venturi N; Spaggiari S
    Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacology of selective inhibition of COX-2.
    Grosser T
    Thromb Haemost; 2006 Oct; 96(4):393-400. PubMed ID: 17003913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The safety of COX-2 inhibitors].
    Lakatos G; Herszényi L; Tulassay Z
    Orv Hetil; 2008 Aug; 149(33):1539-47. PubMed ID: 18687572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.
    St Germaine CG; Bogaty P; Boyer L; Hanley J; Engert JC; Brophy JM
    Am J Cardiol; 2010 Jun; 105(12):1740-5. PubMed ID: 20538124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal damage by non-steroidal anti-inflammatory drugs: updated clinical considerations.
    Pellicano R
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):255-61. PubMed ID: 25384803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.
    Patrignani P; Patrono C
    Biochim Biophys Acta; 2015 Apr; 1851(4):422-32. PubMed ID: 25263946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
    Fosslien E
    Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.